Veeda Oncology, a full service Oncology CRO with headquarters in Columbus, Ohio, has launched a valued new service line as part of its Site Management Services (SMO), Virtual Research Management (VRM), for community-based oncology practices.
Virtual Research Management is a program that will provide management services to community-based oncology practices to enhance research program success. These services are individualized based on Veeda’s initial assessment of needs in collaboration with the practice preferences in areas such as strategic and financial planning, and operational support. By providing additional tools and resources, our services are meant to supplement current research programs in areas of existing need. This program has been successfully piloted at several community-based sites.
Sharon Jameson, BSN, MBA, Vice President, Clinical Development and Operations for the Veeda Oncology’s site management organization (SMO), stated, “Community based practices face many challenges in conducting oncology clinical trials in today’s economic environment. The primary challenges are meeting accrual goals while maintaining economic stability of the research program”.
“Veeda Oncology’s Research Management program has definitely elevated our ability to manage our research program both operationally and financially.” Administrator, NM practice
Veeda Oncology is a global Oncology CRO with operations in the US, Eastern/Western Europe and India. The company is a full service Oncology CRO for Phase I through Phase IV studies with the unique capability of providing rapid and strong global patient accrual with an effective cost structure.
Veeda Oncology is part of the Veeda Group that includes Veeda Clinical Research (Veeda CR), which is a leading CRO specializing in the early clinical development of drugs. With state of the art clinical pharmacology units in the UK, Europe and India, fully accredited GLP Laboratories and an established Biometrics team in Belgium and India, Veeda CR is able to offer clients a full range of Phase I-IIa services.
For further information, please contact:
Jilmil Joshi
Or
Sharon Jameson
